Roche, GSK lung-cancer drug candidates show promise in China
J.P. Morgan analysts said clinical-trial data in China-only studies look strong for lung-cancer candidates from Roche and GSK’s partners.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
J.P. Morgan analysts said clinical-trial data in China-only studies look strong for lung-cancer candidates from Roche and GSK’s partners.